Under Innovate UK’s Knowledge Transfer Partnership (KTP) programme, 52 North Health and the University of Cambridge have been awarded £200,000 to help in research programmes. The Hauser Forum-based MedTech company 52 North Health is best known for its NeutroCheck device. The NeutroCheck is a low-cost device that’s used for testing suspected neutropenic sepsis at home. Also, the company won the Tech for Good Award at the recent Cambridge Independent Science & Technology Awards 2022. 

The KTP programme, which was founded in 1975, aims to create a connection between forward-thinking businesses and the UK's world-class knowledge bases in order to deliver business-led innovation projects for growth.

This award will mainly fund the creation of a new post for an immunoassay scientist for two and a half years. The scientists will develop and validate new antibodies to create the next generation of low-cost rapid diagnostic solutions. This programme also includes a bespoke residential training project.

The group leader at the Department of Chemistry at the University of Cambridge, Dr Pietro Sormanni, has said: “From an academic standpoint, this partnership represents the unique opportunity to translate the fundamental research we carry out into clinical reality, with the potential to greatly improve the healthcare journey of many patients.”